{"id":2687,"date":"2019-06-17T07:11:34","date_gmt":"2019-06-17T05:11:34","guid":{"rendered":"https:\/\/staging.blogs.yokogawa.de\/chemical-pharma\/uncategorized\/crucial-basic-measures-to-ensure-business-resilience-part-2-2\/"},"modified":"2022-06-17T09:28:37","modified_gmt":"2022-06-17T07:28:37","slug":"crucial-basic-measures-to-ensure-business-resilience-part-2-2","status":"publish","type":"post","link":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/crucial-basic-measures-to-ensure-business-resilience-part-2-2\/","title":{"rendered":"Crucial basic measures to ensure business resilience (Part 2\/2)"},"content":{"rendered":"<p>After the <a href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/?p=8902\" target=\"_blank\" rel=\"noopener noreferrer\">first part<\/a> of this blog article focused on the core tasks of Business Impact Analysis (BIA) and the foundations for resilience via Identity and Access Management (IAM), the second part now follows. Here the core tasks are to be brought up for discussion up to advantages of the Identity and Access management.<\/p>\n<h2><strong>Main functions of Identity and Access Management<\/strong><\/h2>\n<p>The most important function of Identity and Access Management is to manage user accounts and access permissions. Before they can be granted access rights, users must be authenticated and authorized by the system. \u201cAuthentication\u201d is when a user proves to the system that they are the person they claim to be. This can involve a simple prompt to enter a user name and password or alternatively a multi-factor method requiring a security token or biometric features. The next step once the user\u2019s identity has been established beyond all doubt is authorization. \u201cAuthorization\u201d determines which systems or resources the user is allowed to access. Authorization is based on more or less complex rules and role concepts, which are normally stored in a database. These rules and roles may be freely definable or instead dependent on the company\u2019s organizational structure and the user\u2019s work domain.<\/p>\n<p>Yet authentication and authorization are not the only tasks performed by Identity and Access Management systems. They also provide self-service user interfaces and run automated processes for granting and provoking user rights with extensive options for information or intervention.<\/p>\n<h3>The most important functions of an IAM system can be summarized as follows:<\/h3>\n<ul>\n<li>Centralized management of identities and access permissions<\/li>\n<li>User authentication and authorization<\/li>\n<li>Centralized access control<\/li>\n<li>Mapping complex rules for access permissions and alignment with organizational structures where necessary<\/li>\n<li>Role based access rights<\/li>\n<li>Multi-factor authentication<\/li>\n<li>Self-services for users such as password reset<\/li>\n<li>Single sign-on services for access to multiple systems and resources using a single identity<\/li>\n<\/ul>\n<h2><strong>Advantages of Identity and Access Management<\/strong><\/h2>\n<p>Particularly in large companies, there may be many different identities and access permissions that need to be managed. IAM systems can provide and ensure the functionality to do this efficiently \u2013 and such that all access permissions are in conformity with internal and external policies. They prevent administrators from losing track of identities and access rights because the number of individual, decentralized approval and authorization processes is so enormous. Users and their rights are governed by a clearly defined structure and can be centrally managed. This reduces the risks of unauthorized access to a minimum, both by internal users and by external users such as customers or partners.<\/p>\n<p>IAM systems make user registration more straightforward, and the authentication and authorization processes are automated. All access rights which are granted are thus guaranteed to correspond to the user\u2019s actual role within the organization. And thanks to the self-service interfaces for users and the high degree of automation, the time and effort for administrators is minimized.<\/p>\n<p>The concept of Identity Management is not only simple. It\u2019s basic and it\u2019s fundamental to security.<\/p>\n<hr \/>\n<p>You haven&#8217;t read <strong>the first part of this blog article<\/strong> yet? Then you are welcome to do so <strong><a href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/?p=8902\">here<\/a><\/strong>!<\/p>\n<p><em>By the way: If you firmly anchor <strong>Plant Security<\/strong> in your company and thus make it fit for the future and are looking for concentrated expertise in this area, you should definitely take a look <strong><a href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/?p=8902\">here<\/a> <\/strong>and register for our<strong> first Plant Security Convention<\/strong> on September 11 of this year in Basel.<\/em><\/p>\n<hr \/>\n<blockquote class=\"wp-embedded-content\" data-secret=\"DQdS47B2N2\"><p><a href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/safety-security-en\/crucial-basic-measures-to-ensure-business-resilience-part-1-2\/\">Crucial basic measures to ensure business resilience (Part 1\/2)<\/a><\/p><\/blockquote>\n<p><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; clip: rect(1px, 1px, 1px, 1px);\" title=\"&#8220;Crucial basic measures to ensure business resilience (Part 1\/2)&#8221; &#8212; Chemical Pharma Blog\" src=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/safety-security-en\/crucial-basic-measures-to-ensure-business-resilience-part-1-2\/embed\/#?secret=uYtpq9e2ug#?secret=DQdS47B2N2\" data-secret=\"DQdS47B2N2\" width=\"500\" height=\"282\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe><\/p>\n<blockquote class=\"wp-embedded-content\" data-secret=\"mkEbaHI5xT\"><p><a href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/security-en\/digital-ambition-key-aspect-plant-security\/\">Digital ambition \u2013 key aspect Plant Security<\/a><\/p><\/blockquote>\n<p><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; clip: rect(1px, 1px, 1px, 1px);\" title=\"&#8220;Digital ambition \u2013 key aspect Plant Security&#8221; &#8212; Chemical Pharma Blog\" src=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/security-en\/digital-ambition-key-aspect-plant-security\/embed\/#?secret=3SJyeP6M9y#?secret=mkEbaHI5xT\" data-secret=\"mkEbaHI5xT\" width=\"500\" height=\"282\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe><\/p>\n<blockquote class=\"wp-embedded-content\" data-secret=\"mESIW03WHk\"><p><a href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/safety-security-en\/ci-what-is-it-actually-part-1\/\">CI &#8211; what is it actually? (Part 1)<\/a><\/p><\/blockquote>\n<p><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; clip: rect(1px, 1px, 1px, 1px);\" title=\"&#8220;CI &#8211; what is it actually? (Part 1)&#8221; &#8212; Chemical Pharma Blog\" src=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/safety-security-en\/ci-what-is-it-actually-part-1\/embed\/#?secret=nBNkfvwypN#?secret=mESIW03WHk\" data-secret=\"mESIW03WHk\" width=\"500\" height=\"282\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe><\/p>\n","protected":false},"excerpt":{"rendered":"<p>After the first part of the blog article &#8220;Decisive basic measures to ensure corporate resilience&#8221; focused on the core tasks of Business Impact Analysis (BIA) and the foundations for resilience via Identity and Access Management (IAM), the second part now&hellip; <\/p>\n<p class=\"read-more\"> <a class=\"\" href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/crucial-basic-measures-to-ensure-business-resilience-part-2-2\/\"> <span class=\"screen-reader-text\">Crucial basic measures to ensure business resilience (Part 2\/2)<\/span> Read More &raquo;<\/a><\/p>\n","protected":false},"author":117,"featured_media":7135,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"","footnotes":""},"categories":[59,60],"tags":[564,82,447,94,561,565,562,189,139,67,283,444,563,73,74,78],"coauthors":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.13 (Yoast SEO v20.13) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Crucial basic measures to ensure business resilience (Part 2\/2) - Chemical Pharma Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/crucial-basic-measures-to-ensure-business-resilience-part-2-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Crucial basic measures to ensure business resilience (Part 2\/2)\" \/>\n<meta property=\"og:description\" content=\"After the first part of the blog article &quot;Decisive basic measures to ensure corporate resilience&quot; focused on the core tasks of Business Impact Analysis (BIA) and the foundations for resilience via Identity and Access Management (IAM), the second part now&hellip;  Crucial basic measures to ensure business resilience (Part 2\/2) Read More &raquo;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/crucial-basic-measures-to-ensure-business-resilience-part-2-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Chemical Pharma Blog\" \/>\n<meta property=\"article:published_time\" content=\"2019-06-17T05:11:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-06-17T07:28:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/AdobeStock_141997027-scaled.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fatma Evren\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/crucial-basic-measures-to-ensure-business-resilience-part-2-2\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/crucial-basic-measures-to-ensure-business-resilience-part-2-2\/\"},\"author\":{\"name\":\"Fatma Evren\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/person\/bef25632a9874d43e7fe7dbe212050ad\"},\"headline\":\"Crucial basic measures to ensure business resilience (Part 2\/2)\",\"datePublished\":\"2019-06-17T05:11:34+00:00\",\"dateModified\":\"2022-06-17T07:28:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/crucial-basic-measures-to-ensure-business-resilience-part-2-2\/\"},\"wordCount\":608,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#organization\"},\"keywords\":[\"Access Management\",\"Automation\",\"BIA\",\"digitalisation\",\"IAM\",\"Identity\",\"Identity Access Management\",\"industry\",\"Industry 4.0\",\"Optimisation\",\"Plant Security\",\"process\",\"Resilience\",\"Safety\",\"Security\",\"Systems\"],\"articleSection\":[\"Safety &amp; Security\",\"Security\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/crucial-basic-measures-to-ensure-business-resilience-part-2-2\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/crucial-basic-measures-to-ensure-business-resilience-part-2-2\/\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/crucial-basic-measures-to-ensure-business-resilience-part-2-2\/\",\"name\":\"Crucial basic measures to ensure business resilience (Part 2\/2) - Chemical Pharma Blog\",\"isPartOf\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#website\"},\"datePublished\":\"2019-06-17T05:11:34+00:00\",\"dateModified\":\"2022-06-17T07:28:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/crucial-basic-measures-to-ensure-business-resilience-part-2-2\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/crucial-basic-measures-to-ensure-business-resilience-part-2-2\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/crucial-basic-measures-to-ensure-business-resilience-part-2-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Crucial basic measures to ensure business resilience (Part 2\/2)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#website\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/\",\"name\":\"Chemical Pharma Blog\",\"description\":\"Yokogawa&#039;s Chemical &amp; Pharma Blog\",\"publisher\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#organization\",\"name\":\"Chemical Pharma Blog\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png\",\"contentUrl\":\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png\",\"width\":302,\"height\":89,\"caption\":\"Chemical Pharma Blog\"},\"image\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/person\/bef25632a9874d43e7fe7dbe212050ad\",\"name\":\"Fatma Evren\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/person\/image\/705d9e7d4dc124ce066ce1502b785235\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9dfa0b587fc6749dc929dd6ff1c83bf0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9dfa0b587fc6749dc929dd6ff1c83bf0?s=96&d=mm&r=g\",\"caption\":\"Fatma Evren\"},\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/author\/fatma-evren\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Crucial basic measures to ensure business resilience (Part 2\/2) - Chemical Pharma Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/crucial-basic-measures-to-ensure-business-resilience-part-2-2\/","og_locale":"en_US","og_type":"article","og_title":"Crucial basic measures to ensure business resilience (Part 2\/2)","og_description":"After the first part of the blog article \"Decisive basic measures to ensure corporate resilience\" focused on the core tasks of Business Impact Analysis (BIA) and the foundations for resilience via Identity and Access Management (IAM), the second part now&hellip;  Crucial basic measures to ensure business resilience (Part 2\/2) Read More &raquo;","og_url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/crucial-basic-measures-to-ensure-business-resilience-part-2-2\/","og_site_name":"Chemical Pharma Blog","article_published_time":"2019-06-17T05:11:34+00:00","article_modified_time":"2022-06-17T07:28:37+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/AdobeStock_141997027-scaled.jpeg","type":"image\/jpeg"}],"author":"Fatma Evren","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/crucial-basic-measures-to-ensure-business-resilience-part-2-2\/#article","isPartOf":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/crucial-basic-measures-to-ensure-business-resilience-part-2-2\/"},"author":{"name":"Fatma Evren","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/person\/bef25632a9874d43e7fe7dbe212050ad"},"headline":"Crucial basic measures to ensure business resilience (Part 2\/2)","datePublished":"2019-06-17T05:11:34+00:00","dateModified":"2022-06-17T07:28:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/crucial-basic-measures-to-ensure-business-resilience-part-2-2\/"},"wordCount":608,"commentCount":0,"publisher":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#organization"},"keywords":["Access Management","Automation","BIA","digitalisation","IAM","Identity","Identity Access Management","industry","Industry 4.0","Optimisation","Plant Security","process","Resilience","Safety","Security","Systems"],"articleSection":["Safety &amp; Security","Security"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/crucial-basic-measures-to-ensure-business-resilience-part-2-2\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/crucial-basic-measures-to-ensure-business-resilience-part-2-2\/","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/crucial-basic-measures-to-ensure-business-resilience-part-2-2\/","name":"Crucial basic measures to ensure business resilience (Part 2\/2) - Chemical Pharma Blog","isPartOf":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#website"},"datePublished":"2019-06-17T05:11:34+00:00","dateModified":"2022-06-17T07:28:37+00:00","breadcrumb":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/crucial-basic-measures-to-ensure-business-resilience-part-2-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/crucial-basic-measures-to-ensure-business-resilience-part-2-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/crucial-basic-measures-to-ensure-business-resilience-part-2-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/"},{"@type":"ListItem","position":2,"name":"Crucial basic measures to ensure business resilience (Part 2\/2)"}]},{"@type":"WebSite","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#website","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/","name":"Chemical Pharma Blog","description":"Yokogawa&#039;s Chemical &amp; Pharma Blog","publisher":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#organization","name":"Chemical Pharma Blog","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png","contentUrl":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png","width":302,"height":89,"caption":"Chemical Pharma Blog"},"image":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/person\/bef25632a9874d43e7fe7dbe212050ad","name":"Fatma Evren","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/#\/schema\/person\/image\/705d9e7d4dc124ce066ce1502b785235","url":"https:\/\/secure.gravatar.com\/avatar\/9dfa0b587fc6749dc929dd6ff1c83bf0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9dfa0b587fc6749dc929dd6ff1c83bf0?s=96&d=mm&r=g","caption":"Fatma Evren"},"url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/author\/fatma-evren\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/AdobeStock_141997027-scaled.jpeg",2560,1707,false],"thumbnail":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/AdobeStock_141997027-150x150.jpeg",150,150,true],"medium":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/AdobeStock_141997027-300x200.jpeg",300,200,true],"medium_large":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/AdobeStock_141997027-768x512.jpeg",768,512,true],"large":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/AdobeStock_141997027-1024x683.jpeg",1024,683,true],"1536x1536":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/AdobeStock_141997027-1536x1024.jpeg",1536,1024,true],"2048x2048":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/AdobeStock_141997027-2048x1365.jpeg",2048,1365,true],"post-thumbnail":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/AdobeStock_141997027-356x200.jpeg",356,200,true]},"uagb_author_info":{"display_name":"Fatma Evren","author_link":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/author\/fatma-evren\/"},"uagb_comment_info":0,"uagb_excerpt":"After the first part of the blog article \"Decisive basic measures to ensure corporate resilience\" focused on the core tasks of Business Impact Analysis (BIA) and the foundations for resilience via Identity and Access Management (IAM), the second part now&hellip; Crucial basic measures to ensure business resilience (Part 2\/2) Read More &raquo;","_links":{"self":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/posts\/2687"}],"collection":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/users\/117"}],"replies":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/comments?post=2687"}],"version-history":[{"count":1,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/posts\/2687\/revisions"}],"predecessor-version":[{"id":11131,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/posts\/2687\/revisions\/11131"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/media\/7135"}],"wp:attachment":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/media?parent=2687"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/categories?post=2687"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/tags?post=2687"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/en\/wp-json\/wp\/v2\/coauthors?post=2687"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}